European Healthcare Expenditure on Over-The-Counter Medicines by Country

The data on European healthcare expenditure on over-the-counter (OTC) medicines in 2024, expressed in Euros per capita, reveals significant variations among countries. The United Kingdom leads with €151.02 per capita, showing a slight year-on-year growth of 0.97%. Switzerland follows with €144.96, growing by 1.54%. Austria and Sweden also exhibit an upward trend with €132.08 and €127.03, respectively, reflecting increases of 2.16% and 2.55%. On the contrary, Luxembourg (€124) and Liechtenstein (€114.06) show declining trends with -1.93% and -1.3%. Notable upward trends are observed in Romania (€99.06) with 15.54% and Poland (€103.41) with 3.71%. Other countries like France (€39.05) and Croatia (€27.65) are seeing declines, -4.18% and -2.12%, respectively.

• The UK (€151.02) – growth of 0.97% YoY
• Switzerland (€144.96) – growth of 1.54% YoY
• Austria (€132.08) – growth of 2.16% YoY
• Sweden (€127.03) – growth of 2.55% YoY
• Luxembourg (€124) – decline of -1.93% YoY
• Liechtenstein (€114.06) – decline of -1.3% YoY
• Cyprus (€113.81) – growth of 3.73% YoY
• Iceland (€109.44) – decline of -0.8% YoY
• Poland (€103.41) – growth of 3.71% YoY
• Romania (€99.06) – substantial growth of 15.54% YoY
• Germany (€96.76) – growth of 4.51% YoY
• Latvia (€93.15) – growth of 4.32% YoY
• Slovenia (€88.39) – growth of 6.83% YoY
• Spain (€79.09) – growth of 1.65% YoY
• Czech Republic (€78.84) – growth of 8.4% YoY
• Belgium (€68.91) – slight growth of 0.56% YoY
• Finland (€67.96) – growth of 1.09% YoY
• Denmark (€57.67) – growth of 1.39% YoY
• Bosnia and Herzegovina (€51.29) – growth of 1.39% YoY
• Estonia (€49.73) – growth of 1.78% YoY
• Slovakia (€48.11) – growth of 3.75% YoY
• Malta (€41.06) – growth of 6.44% YoY
• France (€39.05) – decline of -4.18% YoY
• Croatia (€27.65) – decline of -2.12% YoY

Looking ahead, one should monitor economic factors influencing disposable income, regulatory changes affecting OTC medicine markets, and advancements in e-commerce and digital healthcare services, which could alter expenditure patterns significantly. Rising healthcare awareness and self-medication trends could also drive OTC medicine sales upward.